# Effects of Different Doses of Ticagrelor on Platelet Aggregation and Endothelial Function in Diabetic Patients With Stable Coronary Artery Disease

> **NCT02889549** · PHASE2,PHASE3 · UNKNOWN · sponsor: **First Affiliated Hospital of Harbin Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** ticagrelor
- **DRUG:** clopidogrel

## Key facts

- **NCT ID:** NCT02889549
- **Lead sponsor:** First Affiliated Hospital of Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2017-10
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02889549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02889549, "Effects of Different Doses of Ticagrelor on Platelet Aggregation and Endothelial Function in Diabetic Patients With Stable Coronary Artery Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02889549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*